Endocrine Reviews

Endocrine Reviews (commonly abbreviated as ''Endocr. Rev.') is a peer-reviewed academic journal owned by The Endocrine Society and published by Oxford University Press since 2018, issued six times a year. It publishes reviews only, spanning experimental and clinical endocrinology, and ranks among the most heavily cited review journals in endocrinology.《内分泌学评论》（Endocrine Reviews'，常用缩写为 Endocr. Rev.'''''）是由美国内分泌学会（The Endocrine Society）所有、自二〇一八年起由牛津大学出版社出版的同行评审学术期刊，每年出版六期。该刊只刊发综述，涵盖实验与临床内分泌学的各个方向，是内分泌学领域引用量最高的综述刊物之一。

Scope

The journal operates at two levels: concise timely reviews that update key mechanistic and clinical concepts, and more comprehensive authoritative reviews that address a whole theme in experimental or clinical endocrinology. The dual structure means that within one area of research a short update may appear first and a full treatment some years later, the two serving different functions, of different length and with different citation lifetimes. Its principal subject areas include:本刊的体裁取向是双层的：既发表简明及时的综述以更新关键机制与临床概念，也发表更长、更具权威性的综述以系统处理某一实验或临床内分泌学主题。这一双层结构意味着同一研究领域内既可能有一篇用于更新的短综述，也可能在稍后出现一篇梳理全貌的长综述，二者功能不同、篇幅不同、引用寿命也不同。收文覆盖的主要方向包括：^[1]

• Glands and organ function: physiology and pathophysiology of the pituitary, thyroid, adrenal glands, gonads and pancreatic islets.内分泌腺与器官功能： 垂体、甲状腺、肾上腺、性腺与胰岛的生理与病理生理。

• Mechanisms of hormone action: receptor biology and signal transduction, regulation of hormone synthesis and secretion, and the molecular basis of hormone resistance.激素作用机制： 受体生物学与信号转导、激素合成与分泌的调控、激素抵抗的分子基础。

• Bone and mineral metabolism: bone formation and resorption, calcium, phosphorus and vitamin D metabolism, and skeletal endocrinology.骨与钙磷代谢： 骨形成与骨吸收、钙磷与维生素 D 代谢、骨骼内分泌学。

• Metabolism and obesity: insulin action and insulin resistance, regulation of energy metabolism, and obesity and its complications.代谢与肥胖： 胰岛素作用与胰岛素抵抗、能量代谢调控、肥胖及其并发症。

• Reproductive endocrinology: regulation of the gonadal axes, the reproductive cycle, gametogenesis, and endocrine interventions.生殖内分泌： 性腺轴的调控、生殖周期、配子发生与内分泌干预。

• Oncological and developmental endocrinology: the molecular basis of endocrine tumours, and endocrine regulation in embryonic and developmental contexts.肿瘤与发育内分泌： 内分泌肿瘤的分子基础、胚胎与发育中的内分泌调控。

The journal is published in hybrid mode and authors are not charged on the subscription route. Because it is commissioned by and large, an acceptance rate does not apply and the publisher publishes none本刊属混合出版模式，订阅路线不向作者收费。本刊以约稿为主，故不适用常规录用比例，出版社亦未公布；出版社的官方指标页公布的是影响因子、引用分数与使用量等指标。 what the publisher's official metrics page reports is the impact factor, the CiteScore and usage figures.^[2]

History

• Founding context (1980): the journal appeared in January 1980 as a review title launched by The Endocrine Society after Endocrinology (1917), the Journal of Clinical Endocrinology (1941) and Molecular Endocrinology (1987), appearing four times a year at first. It did not arise by renaming any earlier title, and the society's official history records it as founded outright in 1980, with Donald Gann as its first editor-in-chief.创刊背景（1980年）： 本刊于 1980 年 1 月出版创刊号，是美国内分泌学会继《内分泌学》（1917 年）、《临床内分泌学杂志》（1941 年）与《分子内分泌学》（1987 年）之后新设的综述刊，创刊时每年四期。它并非由任何前身刊改名而来，学会官方史料明确记载其为一九八〇年的全新创刊。首任主编为唐纳德·甘恩。^[3]

• An absorbed yearbook: the society's yearbook Recent Progress in Hormone Research was published under the editorial auspices of this journal, its copyright page stating that it was issued under the editorial auspices of Endocrine Reviews, and was later absorbed into the journal. The arrangement indicates that at founding the title carried two of the society's review functions at once.吸收的年刊： 学会的年刊《激素研究最新进展》在本刊编辑部主持下出版，其卷首版权页注明该年刊由《内分泌学评论》编辑部主持刊行，后被本刊吸收。这条沿革说明本刊创刊时同时承担了学会综述出版的两个功能。^[4]

• Cadence: quarterly from 1980 to 1992, bimonthly from 1993 to 2004, bimonthly with a special May issue from 2005 to 2009, and six issues a year since 2010.刊期演进： 本刊 1980 至 1992 年为季刊，1993 至 2004 年为双月刊，2005 至 2009 年为含五月特刊的双月刊，自 2010 年起每年出版六期。^[5]

• Publisher transition (from 2018): the journal was published by the society itself from 1980 to 2017 and has been published by Oxford University Press since volume 39, that is since 2018. The society has remained the owner throughout, the official formulation being that it is owned by the society and published under contract with the press, so this was a change in who publishes on its behalf rather than a transfer of ownership.出版方变更（2018年起）： 本刊一九八〇至二〇一七年由学会自行出版，自第 39 卷即二〇一八年起改由牛津大学出版社出版。学会始终是所有者，官方口径为「学会所有、委托牛津大学出版社出版」，因此这一变更属出版代管关系的变化，而非所有权转移。^[2]

• Metric standing: the publisher's official metrics page reports a 2025 impact factor of 23.9 and a five-year factor of 34.1, fifth among 198 titles in endocrinology and metabolism in the Journal Citation Reports with an immediacy index of 3.9, and a 2025 Scopus CiteScore of 56.5, second among 250 titles in endocrinology, diabetes and metabolism and second among 132 in endocrinology proper.指标水平： 出版社官方指标页显示，本刊二〇二五年影响因子 23.9、五年影响因子 34.1，在期刊引证报告的内分泌学与代谢类 198 种期刊中列第五位，即时指数 3.9；同年斯科普斯引用分数 56.5，在内分泌、糖尿病与代谢类 250 种期刊中列第二，在内分泌学类 132 种中同样列第二。^[2]

Editors

The journal is run by an editor-in-chief, and since commissioned reviews are its principal source of material, the editorial work lies in topic selection and solicitation rather than in refereeing. The publisher reports neither an acceptance rate nor a time to first decision for this title, neither being meaningful for a largely commissioned journal.本刊实行主编统筹的架构，以约稿为主要稿件来源，因此编辑工作的重心在于选题与邀稿，而非审稿。出版社不公布本刊的录用比例与首决时长——这两项指标对一份以约稿为主的刊物并不适用。^[2]

• Ashley Grossman (editor-in-chief since January 2022): professor of endocrinology at the University of Oxford on an initial three-year term. He is also professor of neuroendocrinology at a London university and consultant in neuroendocrine tumours at a London hospital. His dual clinical and academic appointment places the editorship directly at the front line of clinical and translational endocrine work.阿什利·格罗斯曼（2022年1月起任）： 牛津大学内分泌学教授，首个任期三年；他还兼任伦敦大学神经内分泌学教授，并在伦敦皇家自由医院担任神经内分泌肿瘤会诊医师。其学术身份使本刊的主编职位直接落在内分泌学的临床与转化研究一线。^[6]

• Leonard Wartofsky (2015–2021): he took the editorship formally after Chip Ridgway died suddenly and Margaret Wierman had served in an acting capacity, and held the post until 2021. Under him the journal completed its handover from society self-publication to publication by Oxford University Press.伦纳德·沃托夫斯基（2015—2021年）： 在奇普·里奇韦突发去世后由玛格丽特·维耶曼代理主编，沃托夫斯基随后正式接任，至二〇二一年止。他任内本刊完成了从学会自营到牛津大学出版社出版的交接。^[7]

• Founding editor: Donald Gann was editor-in-chief from the journal's founding in 1980, after which the post passed through Andres Negro-Vilar, Pentti Siiteri, Marc Caron, E. Brad Thompson, R. Paul Robertson, Chip Ridgway, Margaret Wierman in an acting capacity, and Wartofsky before Grossman, a succession running unbroken for more than four decades.创刊主编： 唐纳德·甘恩自一九八〇年创刊起任主编，其后本刊主编职位历经安德烈斯·内格罗-维拉尔、佩恩蒂·西特里、马克·卡伦、伊·布拉德·汤普森、R·保罗·罗伯逊、奇普·里奇韦、玛格丽特·维耶曼与沃托夫斯基，直至格罗斯曼，构成一条延续四十余年的主编任职链。^[6]

• Standing in the field: one of the most broadly cited review journals in endocrinology, whose long-form reviews are repeatedly cited as baseline accounts of how the field's concepts are structured, and which therefore plays an organizing role in how those concepts are formed and circulated.学科地位： 本刊是内分泌学领域被引用最广的综述刊之一，其长综述常作为该领域概念框架的基准文本被后续研究反复引用，因此在概念的形成与传播上承担着组织者的角色。^[1]